| P50 | author | Roisin Worsley | Q41638071 |
| | Tamsyn E Van Rheenen | Q44021815 |
| | Wei Chun Wang | Q59503533 |
| | Paul B. Fitzgerald | Q37838866 |
| P2093 | author name string | Kay McCauley | |
| | Jayashri Kulkarni | |
| | Emorfia Gavrilidis | |
| | Heather Gilbert | |
| P2860 | cites work | WHO European review of social determinants of health and the health divide | Q38042210 |
| | Road testing the newer antipsychotic agents. | Q39353925 |
| | Preliminary findings from the National Register of Antipsychotic Medication in Pregnancy | Q40146961 |
| | Predictors of parenting outcome in women with psychotic disorders discharged from mother and baby units. | Q40478761 |
| | Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy | Q44414924 |
| | Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study | Q45048635 |
| | Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis | Q45260923 |
| | Risk of stillbirth and neonatal death linked with maternal mental illness: a national cohort study | Q45893434 |
| | Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. | Q46427035 |
| | Psychosocial characteristics and needs of mothers with psychotic disorders | Q46521964 |
| | Off-label use of antipsychotic medications in Medicaid. | Q46839316 |
| | Maternal bipolar disorder increased low birthweight and preterm births: a nationwide population-based study | Q48398459 |
| | Breastfeeding and psychotropic medications | Q48497227 |
| | National trends in the office-based treatment of children, adolescents, and adults with antipsychotics | Q48631822 |
| | Sexuality, pregnancy, and childrearing among women with schizophrenia-spectrum disorders. | Q51018503 |
| | Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. | Q51021763 |
| | The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy. | Q51030042 |
| | More than half the women with a history of psychosis have a psychiatric episode in the first year after childbirth. | Q51930810 |
| | Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants. | Q52190290 |
| | Neonatal abstinence syndrome: assessment and management | Q52264725 |
| | The psychosocial outcome of pregnancy in women with psychotic disorders | Q57470994 |
| | Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation | Q80139155 |
| | Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes | Q80726423 |
| | 'About Helen'--antipsychotic medication use during pregnancy. A case study | Q83480520 |
| | Prevention of postpartum psychosis and mania in women at high risk | Q83620607 |
| | Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects | Q84509541 |
| | Bringing postnatal depression out of the shadows | Q85406491 |
| | Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum | Q24247219 |
| | Increasing off-label use of antipsychotic medications in the United States, 1995-2008 | Q24628874 |
| | Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q28111913 |
| | Meeting MDG-5: an impossible dream? | Q29301055 |
| | Prenatal stress: role in psychotic and depressive diseases | Q30470115 |
| | Antipsychotic therapy during early and late pregnancy. A systematic review | Q33369019 |
| | Use of psychotropic medications in breast-feeding women: acute and prophylactic treatment | Q33543077 |
| | The fertility and fecundity of patients with psychoses | Q33688500 |
| | National trends in antidepressant medication treatment among publicly insured pregnant women | Q33830556 |
| | National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 |
| | Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale | Q34186484 |
| | Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs | Q34338202 |
| | Obstetric complications and schizophrenia: historical and meta-analytic review | Q34524766 |
| | Antipsychotics and breastfeeding | Q34533818 |
| | Maternal use of antipsychotics in early pregnancy and delivery outcome. | Q34591997 |
| | Depressive disorders during pregnancy: prevalence and risk factors in a large urban sample | Q34746749 |
| | Maternal mental health in pregnancy and child behavior | Q35702136 |
| | Gender differences in the prescribing of antipsychotic drugs | Q35851946 |
| | Prenatal psychobiological predictors of anxiety risk in preadolescent children | Q35974645 |
| | Developmental screening | Q36080685 |
| | Use of antipsychotics in the management of schizophrenia during pregnancy | Q36139260 |
| | Use of antidepressant medications during pregnancy: a multisite study | Q36955493 |
| | Antipsychotics in pregnancy | Q37751026 |
| | Psychotropics in pregnancy: safety and other considerations | Q38000809 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e94788 | |
| P577 | publication date | 2014-05-02 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies | |
| P478 | volume | 9 | |